stage iii squamous cell carcinoma of the larynx
Showing 1 - 22 of 22
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- erlotinib hydrochloride
- +10 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the
Completed
- Human Papilloma Virus Infection
- +15 more
- paclitaxel
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Aug 10, 2018
Stage I Adenoid Cystic Carcinoma of the Oral Cavity, Stage I Mucoepidermoid Carcinoma of the Oral Cavity, Stage I Squamous Cell
Terminated
- Stage I Adenoid Cystic Carcinoma of the Oral Cavity
- +27 more
- endoscopic procedure
- questionnaire administration
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jun 29, 2018
Nausea and Vomiting, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx Trial
Terminated
- Nausea and Vomiting
- +10 more
- fosaprepitant dimeglumine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 13, 2017
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Terminated
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +45 more
- talactoferrin
- laboratory biomarker analysis
-
Stanford, CaliforniaStanford University
Jul 30, 2016
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent
Terminated
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +54 more
- transoral robotic surgery
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 7, 2014
Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity Trial in Buffalo, Hamilton (dietary supplement, other, drug,
Terminated
- Chemotherapeutic Agent Toxicity
- +15 more
- selenomethionine
- +4 more
-
Buffalo, New York
- +1 more
Aug 8, 2014
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Stage III Squamous Cell Carcinoma of the
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +26 more
- erlotinib hydrochloride
- +5 more
-
Cleveland, OhioCase Western Reserve University
Jun 5, 2014
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Meningioma Trial in Houston (bevacizumab, , magnetic
Completed
- Adult Anaplastic Astrocytoma
- +86 more
- bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 21, 2014
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +38 more
- saracatinib
- laboratory biomarker analysis
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 2, 2014
Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the
Completed
- Recurrent Salivary Gland Cancer
- +21 more
- erlotinib hydrochloride
- +3 more
-
Columbus, OhioOhio State University Medical Center
Nov 21, 2013
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Completed
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +9 more
- erlotinib hydrochloride
- +4 more
-
Anchorage, Alaska
- +8 more
May 8, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +53 more
- hydroxyurea
- +5 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Feb 6, 2013
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +7 more
- gefitinib
- +3 more
-
Denver, ColoradoUniversity of Colorado
Jan 24, 2013
Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)
Completed
- Anaplastic Thyroid Cancer
- +85 more
-
San Antonio, TexasSouthwest Oncology Group
Jan 11, 2013
Recurrent NSCLC, Recurrent Ovarian Epithelial Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx Trial in Chicago
Completed
- Recurrent Non-small Cell Lung Cancer
- +29 more
- erlotinib hydrochloride
- +3 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 8, 2013